In This SectionTexas Health Research & Education Institute
Disease or Condition
Heart / Myocardial Infarction
Trial to Assess the Effects of SCH 530348 in Preventing Heart Attack and Stroke in Patients With Acute Coronary Syndrome (TRA•CER) (Heart / Myocardial Infarction)
The study is designed to determine whether an investigational medicine, when added to the existing standard of care (eg, aspirin, clopidogrel) for preventing heart attack and stroke in patients with acute coronary syndrome, will yield additional benefit over the existing standard of care in preventing heart attack and stroke. The study is also designed to assess risk of bleeding with the investigational medicine added to the standard of care versus the standard of care alone.
Men and women at least 18 years old with current clinical manifestation of non-ST-segment-elevation myocardial infarction (heart attack) according to the following three criteria:
Current symptoms of cardiac ischemia (chest pain leading to cardiac ischemia or heart attack).
either of the following:
Concurrent elevation of troponin I or T, or of creatine kinase - myocardial band (CK-MB) to a level above the upper limit of normal, OR.